There is increasing recognition of discrepancies in the clinical spectrum and prognosis of chronic ulcerative colitis (CUC) in population based studies compared with those based on patient series.'-5 The few investigations utilising the complete cohort of patients from a single community predict a lower incidence of subsequent colon cancer, for example, and a higher survival rate="' than is evident among series of referral patients or hospital admissions. -2X The present study took advantage of the population based medical records linkage system in Rochester, Minnesota, to determine survival and the risk of subsequent colon cancer in community residents with chronic ulcerative colitis.
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Methods

PATIENTS
Population based epidemiologic research is possible in Rochester, Minnesota, because medical care is virtually selfcontained within the community and is delivered by a handful of providers. Most care is provided by the Mayo Clinic, which has maintained a common medical record system with its two large affiliated hospitals over the past 80 years. This dossier type medical record contains both inpatient and outpatient data and is easily retrieved for review."9 The diagnosis and surgical procedures entered into these records are indexed. The index includes the diagnosis made for outpatient office or clinic consultations, emergency room visits, nursing home care, inpatient hospitalisation, autopsy examination, and death certification. The records of the other medical care providers in the area who have served the local population are also indexed and can also be retrieved. Thus, the details of the medical care provided to the residents of the entire community are available for study. The (4) 'severe'-patients who underwent total proctocolectomy, developed toxic megacolon, or died as a result of chronic ulcerative colitis.
Each patient was followed through his or her linked medical records in the community, and those who had not been seen since 1980 were contacted by letter or telephone. Follow up was complete to death or through 1980 in 96%, with a median follow up on these subjects of 14 years. Median follow up on the remainder was 4-4 years. As an additional check for complete ascertainment of colon cancer, the chronic ulcerative colitis cases were cross checked with a listing of all diagnosed colorectal cancer cases in Rochester. 33 The incidence of colorectal adenocarcinoma in this group was compared with the expected incidence (relative risk). The expected incidence was calculated using the age and sex specific person years of follow up in the cohort in conjunction with age and sex specific incidence rates of colorectal adeno- These three individuals were deleted from the group at risk of colon cancer subsequent to the diagnosis of chronic ulcerative colitis. The remaining 179 individuals in the cohort were followed for 2535 person years for the development of colorectal cancer or until total colectomy, death, or date of last follow up. Three patients (cases 3, 4, and 5, Table 1 ) developed adenocarcinoma of the colon subsequent to the diagnosis of chronic ulcerative colitis. An 88 year old man with adenocarcinoma of the transverse colon first had a diagnosis of transient proctitis while a resident of Rochester. He did not have any further evaluation at Mayo Clinic because he subsequently moved from the community. Follow up revealed that he had a partial colon resection and colostomy at age 86 and was found to have cancer of the transverse colon two years afterward. He died several months later. The second patient was a 43 year old man who developed adenocarcinoma at the splenic flexure nine years after the initial chronic ulcerative colitis diagnosis, which was a pancolitis at onset. Two and a half years after the discovery of colon cancer, he died Stonneigtonl, Phillips, Zinsilnicster, and Meltoli of bowel obstruction. The third patient was a 49 year old woman who developed grade 2 adenocarcinoma of the sigmoid colon 16 years after an episode of transient proctitis. No evidence of inflammatory bowel disease was found at the time of sigmoid resection for the cancer. Because this latter individual (case 5) had findings sufficient for a 'probable' diagnosis of chronic ulcerative colitis according to our criteria, we were bound to include her; however, we recognise that the transient proctitis may have had only a coincidental relationship with the later malignancy. A fourth individual, not included here, subsequently developed squamous cell carcinoma of the anus.
The three observed cases reflect an overall incidence of adenocarcinoma of the colon in this cohort of 1 2 per 1000 person years (p-y). The expected incidence, based on colorectal cancer rates for the underlying population of Rochester, was 0(6 per 1000 p-y. The overall relative risk was thus 1 9 (2.7 for men and -1 for women) as shown in Table 2 . Because of the small numbers involved, none of these was statistically significantly greater than the expected relative risk of 1 0. The power of this analysis to have detected a true relative risk >-3 0 was 60% (a(=0(05, (Table 3) . If the patients who otily had proctitis were excluded, the relative risk for the remainder was 2 4 (95%, Cl 0-3-8-7). The cumuliative incidence of colon cancer (2-3°/O at 20 years) was not significantly greater than expected either (Fig. 3) . These results were not substantivally altered if onset of symptomis, raither thian diagnosis, were used as the inception date for initiating foilow up ( Table 2 ). Ten individuals have developed an adenomatous polyp thus fiar, from 0 to 42 years aifter the initial diagnosis of ulcerative colitis. One patient had transient proctitis only and another had recurrent proctitis only. The other eight had more diffuse inflammatory bowel disease. One patient had the polyp diagnosed concurrently with chronic ulcerative colitis; she also had a grade 4 adenocarcinorna diagnosed at the same time, although the otiset of chronic ulcerative colitis symptoms appeared to predate the cancer (case 2, Tiable 1). and died three months later.
Up to the time of last follow up, 145 patients were alive and 37 (20.3(X0) had died (Tatble 4). Of those who had died, chronic ulcerative colitis was the underlying cause of death in six (two definite and four probable cases). Chronic ulcerative colitis wals mentioned elsewhere on the death certificate in four but not as a primary cause of death (all definite cases). Chronic ulcerative colitis was not mentioned on 26 deaths certificates (12 definite and 14 probable cases). The death certificate of the final patient could not be obtained. Overall survival was similar to that expected for members of the general population of like age and sex (Fig. 4) .
Discussion
These data from a population based inception cohort of chronic ulcerative colitis patients corroborate a recent report from another population based study in Denmark," in which survival did not differ significantly from that of the general population. A reported here is little different from the 1-7 per 1000 person year figure seen in a community cohort followed with routine colonoscopy. "' The cumulative incidence of 2-3% at 20 years is also less than that suggested by referral centre data. Four additional individuals have shown evidence of mild dysplasia thus far, from six to 28 years subsequent to their initial chronic ulcerative colitis diagnosis. One patient had a proctocolectomy on the basis of symptoms (not dysplasia); the remaining three have been watched with no further sequelae. It is difficult to make conclusions with regard to dysplasia, however, because a cancer surveillance programme was only instituted within the last decade and because of the small numbers involved. So far, those showing dysplasia have had only mild evidence of such. All four cases had extensive disease of long duration, however, and close watch for progression of dysplasia is definitely warranted in the three whose colons are still intact.
Despite the presence of some severely affected individuals, our results indicate that chronic ulcerative colitis is a milder disease in community patients generally than it is in patients who are hospitalised or referred to tertiary medical centres. The risk of cancer in unselected chronic ulcerative colitis patients from the community appears to be lower than that suggested by referral centre data, and survival is relatively unimpaired. These findings are consistent with clinical spectrum data reported in a previous paper from the same population.' in which we showed a preponderance of less severe disecase than is typically quoted from referral institutions. 
